Skip to main content

Market Overview

12 Health Care Stocks Moving In Tuesday's Intraday Session

Share:
12 Health Care Stocks Moving In Tuesday's Intraday Session

 

Gainers

  • Kala Pharmaceuticals (NASDAQ:KALA) stock rose 86.8% to $1.14 during Tuesday's regular session. The current volume of 2.6 million shares is 326.2% of Kala Pharmaceuticals's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $82.4 million.
  • Voyager Therapeutics (NASDAQ:VYGR) shares increased by 32.56% to $5.21. The current volume of 2.3 million shares is 641.1% of Voyager Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $197.7 million. As per the press release, Q4 earnings came out today.
  • Rain Therapeutics (NASDAQ:RAIN) shares increased by 17.86% to $7.06. The company's market cap stands at $187.1 million. As per the news, the Q4 earnings report came out 3 days ago.
  • IsoPlexis (NASDAQ:ISO) shares rose 16.62% to $4.84. Trading volume for this security as of 12:30 EST is 62.1K, which is 33.4% of its average full-day volume over the last 100 days. The company's market cap stands at $188.9 million. As per the press release, Q4 earnings came out 4 days ago.
  • BioVie (NASDAQ:BIVI) shares moved upwards by 16.25% to $3.37. The company's market cap stands at $84.2 million.
  • Clover Health Investments (NASDAQ:CLOV) stock moved upwards by 15.53% to $3.0. Trading volume for Clover Health Investments's stock is 20.2 million as of 12:30 EST. This is 138.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.4 billion.

 

Losers

  • Yield10 Bioscience (NASDAQ:YTEN) stock declined by 21.6% to $4.31 during Tuesday's regular session. The current volume of 300.8K shares is 310.2% of Yield10 Bioscience's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $21.0 million.
  • GBS (NASDAQ:GBS) shares fell 18.3% to $0.68. GBS's stock is trading at a volume of 865.0K shares as of 12:30 EST. This is 38.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $10.1 million.
  • PetVivo Holdings (NASDAQ:PETV) shares fell 15.68% to $1.56. As of 12:30 EST, this security is trading at a volume of 65.9K shares, making up 18.8% of its average full-day volume over the last 100 days. The company's market cap stands at $15.2 million.
  • Alector (NASDAQ:ALEC) stock fell 15.22% to $12.59. As of 12:30 EST, this security is trading at a volume of 900.8K shares, making up 127.8% of its average full-day volume over the last 100 days. The company's market cap stands at $1.0 billion.
  • Atreca (NASDAQ:BCEL) shares decreased by 14.65% to $2.74. As of 12:30 EST, Atreca's stock is trading at a volume of 2.8 million, which is 176.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $103.4 million. As per the press release, Q4 earnings came out 3 days ago.
  • Avenue Therapeutics (NASDAQ:ATXI) stock fell 13.56% to $0.66. Trading volume for this security as of 12:30 EST is 2.0 million, which is 42.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $13.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

 

Related Articles (ATXI + ALEC)

View Comments and Join the Discussion!

Posted-In: BZI-TFMIntraday Update Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com